von Redaktion LCGC | März 27, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancer Shaw AT, Kim DW, Mehra R, Tan DS, Felip E, Chow LQ, Camidge DR, Vansteenkiste J, Sharma S, De Pas T, Riely GJ, Solomon BJ, Wolf J, Thomas M, Schuler M, Liu G, Santoro A, Lau YY, Goldwasser M, Boral AL, Engelman JA...
von Redaktion LCGC | März 27, 2014
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids Fernandez-Cuesta L, Peifer M, Lu X, Sun R, Ozretić L, Seidel D, Zander T, Leenders F, George J, Müller C, Dahmen I, Pinther B, Bosco G, Konrad K, Altmüller J, Nürnberg P, Achter V, Lang U,...
von Redaktion LCGC | Feb. 4, 2014
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer Malchers F, Dietlein F, Schöttle J, Lu X, Nogova L, Albus K, Fernandez-Cuesta L, Heuckmann JM, Gautschi O, Diebold J, Plenker D, Gardizi M, Scheffler M, Bos M,...
von Redaktion LCGC | Okt. 15, 2013
A Genomics-Based Classification of Human Lung Tumors Journal: The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM), Science Translational Medicine, October 2013. doi: 10.1126/scitranslmed.3006802Veröffentlichung: Oktober...
von Redaktion LCGC | Juli 15, 2013
Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small.cell lung cancer Schultheis A, Bos M, Schmitz K, Wilsberg L, Binot E, Wolf J, Buettner R, Schildhaus HU Journal: Modern Pathology, July 2013....
